Purple Biotech Ltd.
NASDAQ:PPBT
4.36 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| -19.88 | -21.76 | -17.826 | -28.074 | -5.893 | -5.569 | -13.008 | -12.125 | -4.202 | -5.252 | -2.628 | -0.001 |
Depreciation & Amortization
| 0.197 | 0.201 | 0.231 | 0.235 | 0.179 | 0.007 | 0.004 | 0.002 | 0.001 | 0 | 0 | 0 |
Deferred Income Tax
| -0.761 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 1.875 | 2.412 | 2.082 | 2.645 | 1.272 | 0.773 | 2.308 | 0.4 | 0.059 | 0.088 | 0.296 | 0 |
Change In Working Capital
| 0.274 | 3.255 | 0.55 | -2.36 | 0.34 | -0.54 | 0.122 | 0.269 | 0.284 | -0.13 | 0.134 | -0 |
Accounts Receivables
| 0.178 | 0.313 | -0.316 | 0.501 | 0.062 | -1.111 | -0.273 | 0 | 0.197 | -0 | -0.11 | -0 |
Inventory
| 0 | 0 | 0.573 | -0.511 | -0.062 | 0 | 0 | 0 | 0.054 | 0 | 0.11 | 0 |
Accounts Payables
| 1.334 | 0.799 | 0.266 | -2.33 | 0.503 | 0.393 | -0.491 | -0.138 | -0.152 | 0.453 | -0.011 | 0 |
Other Working Capital
| -1.238 | 2.143 | 0.027 | -0.02 | -0.163 | -0.933 | 0.613 | 0.407 | 0.185 | -0.583 | 0.145 | 0 |
Other Non Cash Items
| -0.931 | -0.843 | -0.108 | 15.462 | -1.479 | -3.151 | 1.947 | 5.192 | 0.55 | 0.768 | 1.686 | 0 |
Operating Cash Flow
| -19.226 | -16.735 | -15.071 | -12.092 | -5.581 | -8.48 | -8.627 | -6.262 | -3.308 | -4.526 | -0.512 | -0 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -0.003 | -0.228 | -0.115 | -0.156 | -0.011 | -0.016 | -0.013 | -0.01 | -0.009 | 0 | 0 | 0 |
Acquisitions Net
| -3.549 | 0 | 0 | 0.069 | 0 | 0 | -1.732 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| -0.017 | 0 | 0 | -49.618 | -2.1 | 0 | 0 | -7.899 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 16.678 | 19.818 | 13.162 | 0.041 | 1.511 | 1.967 | 4.411 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0.772 | 0.324 | 0.359 | 0.069 | 0.151 | 2.06 | 4.517 | -7.899 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| 13.881 | 19.914 | 13.406 | -49.595 | -0.449 | 2.044 | 2.772 | -7.909 | -0.009 | 0 | 0 | 0 |
Financing Activities: | ||||||||||||
Debt Repayment
| -0.168 | -0.165 | -0.153 | -0.179 | -0.171 | 0 | 0 | 0 | 0 | 0 | 0.686 | 0 |
Common Stock Issued
| 1.563 | 1.498 | 0.564 | 27.925 | 2.594 | 4.683 | 2.419 | 6.287 | 14.942 | 6.848 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 4.054 | -0.219 | 1.101 | 40.742 | 2.81 | 3.105 | 0.576 | 3.999 | -2.31 | -1.026 | 0.015 | 0 |
Financing Cash Flow
| 5.449 | 1.114 | 1.512 | 68.488 | 5.233 | 7.788 | 2.995 | 10.424 | 12.632 | 5.822 | 0.701 | 0 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0.054 | -0.153 | -0.024 | 0.061 | 0.019 | -0.136 | 0.049 | -0.053 | -0.07 | -0.176 | 0.004 | 0 |
Net Change In Cash
| -0.541 | 4.14 | -0.357 | 6.862 | -0.778 | 1.216 | -2.811 | -3.8 | 9.245 | 1.12 | 0.193 | 0 |
Cash At End Of Period
| 14.489 | 15.03 | 10.89 | 11.247 | 4.385 | 5.163 | 3.947 | 6.758 | 10.558 | 1.313 | 0.193 | 0 |